5 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Hk Inno.N Corporation | 3 |
| BIOTHERYX, INC. | 1 |
| Hk Inno. N Corporation | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18551926 | PYRAZOLYLPYRIMIDINES FOR TREATING MALIGNANT SOLID TUMOR | BIOTHERYX, INC. | GONZALEZ, LUISALBERTO | 1624 | Non-Final OA | Sep 22, 2023 |
| 18269421 | PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | Hk Inno.N Corporation | NGUYEN, JOHN P | 1619 | Non-Final OA | Jun 23, 2023 |
| 17802078 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | Hk Inno. N Corporation | KWON, JOHN SEUNGJAI | 1615 | Final Rejection | Aug 24, 2022 |
| 17802054 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | Hk Inno.N Corporation | GOTFREDSON, GAREN | 1619 | Final Rejection | Aug 24, 2022 |
| 17429732 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | Hk Inno.N Corporation | HUTTER, GILLIAN A | 1625 | Non-Final OA | Aug 10, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial